Q15365 (PCBP1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 120.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Poly(rC)-binding protein 1 Alternative name(s): Alpha-CP1 Heterogeneous nuclear ribonucleoprotein E1 Short name=hnRNP E1 Nucleic acid-binding protein SUB2.3 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 356 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Single-stranded nucleic acid binding protein that binds preferentially to oligo dC. |
| Subcellular location | Nucleus. Cytoplasm. Note: Loosely bound in the nucleus. May shuttle between the nucleus and the cytoplasm. |
| Tissue specificity | Abundantly expressed in skeletal muscle, thymus and peripheral blood leukocytes while a lower expression is observed in prostate, spleen, testis, ovary, small intestine, heart, liver, adrenal and thyroid glands. |
| Post-translational modification | Phosphorylated; lowers poly(rC)-binding activity. Ref.6 Ref.7 Ref.8 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 Ref.16 Ref.17 |
| Sequence similarities | Contains 3 KH domains. |
| Sequence caution | The sequence CAA82631.1 differs from that shown. Reason: Frameshift at position 301. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cytoplasm Nucleus |
| Domain | Repeat |
| Ligand | DNA-binding RNA-binding |
| Molecular function | Ribonucleoprotein |
| PTM | Phosphoprotein |
| Technical term | 3D-structure Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological process | nuclear mRNA splicing, via spliceosome Traceable author statement. Source: Reactome |
| Cellular component | cytoplasm Non-traceable author statement. Source: UniProtKB nucleoplasmTraceable author statement. Source: Reactome ribonucleoprotein complexInferred from electronic annotation. Source: UniProtKB-KW |
| Molecular function | RNA binding Inferred from direct assay Ref.2Ref.1Ref.3. Source: UniProtKB protein bindingInferred from physical interaction. Source: IntAct single-stranded DNA bindingInferred from direct assay Ref.3. Source: UniProtKB |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| PCBP2 | Q15366 | 2 | EBI-946095,EBI-945799 | |
| PTBP1 | P26599 | 2 | EBI-946095,EBI-350540 | |
| PUF60 | Q9UHX1 | 2 | EBI-946095,EBI-1053259 | |
| QKI | Q96PU8 | 2 | EBI-946095,EBI-945792 | |
| TSC22D4 | Q9Y3Q8 | 2 | EBI-946095,EBI-739485 | |
| WBP11 | Q9Y2W2 | 2 | EBI-946095,EBI-714455 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 356 | 356 | Poly(rC)-binding protein 1 | PRO_0000050087 | ||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||
| Domain | 13 – 75 | 63 | KH 1 | |||||||||||||||||||||||||||||
| Domain | 97 – 162 | 66 | KH 2 | |||||||||||||||||||||||||||||
| Domain | 279 – 343 | 65 | KH 3 | |||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||
| Modified residue | 173 | 1 | Phosphoserine Ref.7 Ref.8 Ref.9 Ref.10 Ref.11 Ref.13 Ref.14 Ref.16 Ref.17 | |||||||||||||||||||||||||||||
| Modified residue | 189 | 1 | Phosphoserine Ref.15 | |||||||||||||||||||||||||||||
| Modified residue | 190 | 1 | Phosphoserine Ref.6 Ref.12 Ref.13 Ref.14 Ref.15 Ref.17 | |||||||||||||||||||||||||||||
| Modified residue | 246 | 1 | Phosphoserine Ref.9 | |||||||||||||||||||||||||||||
| Modified residue | 262 | 1 | Phosphoserine Ref.9 | |||||||||||||||||||||||||||||
| Modified residue | 263 | 1 | Phosphoserine Ref.9 | |||||||||||||||||||||||||||||
| Modified residue | 264 | 1 | Phosphoserine Ref.9 Ref.10 | |||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||
| Sequence conflict | 205 | 1 | A → V in CAA55016. Ref.1 | |||||||||||||||||||||||||||||
| Sequence conflict | 299 – 300 | 2 | Missing in CAA82631. Ref.3 | |||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||
| Beta strand | 14 – 21 | 8 | ||||||||||||||||||||||||||||||
| Helix | 22 – 28 | 7 | ||||||||||||||||||||||||||||||
| Helix | 34 – 43 | 10 | ||||||||||||||||||||||||||||||
| Beta strand | 46 – 49 | 4 | ||||||||||||||||||||||||||||||
| Beta strand | 55 – 64 | 10 | ||||||||||||||||||||||||||||||
| Helix | 65 – 80 | 16 | ||||||||||||||||||||||||||||||
| Beta strand | 280 – 287 | 8 | ||||||||||||||||||||||||||||||
| Helix | 288 – 290 | 3 | ||||||||||||||||||||||||||||||
| Helix | 291 – 295 | 5 | ||||||||||||||||||||||||||||||
| Helix | 297 – 299 | 3 | ||||||||||||||||||||||||||||||
| Helix | 300 – 309 | 10 | ||||||||||||||||||||||||||||||
| Beta strand | 312 – 315 | 4 | ||||||||||||||||||||||||||||||
| Beta strand | 323 – 331 | 9 | ||||||||||||||||||||||||||||||
| Helix | 333 – 346 | 14 | ||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Characterisation of two major cellular poly(rC)-binding human proteins, each containing three K-homologous (KH) domains." Leffers H., Dejgaard K., Celis J.E. Eur. J. Biochem. 230:447-453(1995) [PubMed: 7607214] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Identification of two KH domain proteins in the alpha-globin mRNP stability complex." Kiledjian M., Wang X., Liebhaber S.A. EMBO J. 14:4357-4364(1995) [PubMed: 7556077] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Tissue specific expression and cDNA structure of a human transcript encoding a nucleic acid binding [oligo(dC)] protein related to the pre-mRNA binding protein K." Aasheim H.-C., Loukianova T., Deggerdal A., Smeland E.B. Nucleic Acids Res. 22:959-964(1994) [PubMed: 8152927] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Lymphocyte. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Skin. |
| [5] | Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y. Submitted (DEC-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 47-70; 79-115; 125-160; 178-200; 298-306 AND 315-346, MASS SPECTROMETRY. Tissue: Brain, Cajal-Retzius cell and Fetal brain cortex. |
| [6] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [7] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [8] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173; SER-246; SER-262; SER-263 AND SER-264, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "Evaluation of the low-specificity protease elastase for large-scale phosphoproteome analysis." Wang B., Malik R., Nigg E.A., Korner R. Anal. Chem. 80:9526-9533(2008) [PubMed: 19007248] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-264, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column." Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y. Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-190, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-190, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189 AND SER-190, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [16] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed: 19369195] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, MASS SPECTROMETRY. |
| [17] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-190, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [18] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [19] | "Structure and RNA binding of the third KH domain of poly(C)-binding protein 1." Sidiqi M., Wilce J.A., Vivian J.P., Porter C.J., Barker A., Leedman P.J., Wilce M.C. Nucleic Acids Res. 33:1213-1221(2005) [PubMed: 15731341] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 279-356, RNA-BINDING. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X78137 mRNA. Translation: CAA55016.1. U24223 mRNA. Translation: AAA91317.1. Z29505 mRNA. Translation: CAA82631.1. Frameshift. BC039742 mRNA. Translation: AAH39742.1. | ||||||||||||||||||
| IPI | IPI00016610. | ||||||||||||||||||
| RefSeq | NP_006187.2. NM_006196.3. | ||||||||||||||||||
| UniGene | Hs.2853. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | Q15365. | ||||||||||||||||||
| SMR | Q15365. Positions 11-169, 278-348. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| DIP | DIP-38136N. | ||||||||||||||||||
| IntAct | Q15365. 33 interactions. | ||||||||||||||||||
| MINT | MINT-96267. | ||||||||||||||||||
| STRING | Q15365. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | Q15365. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 42560548. | ||||||||||||||||||
2D gel databases | |||||||||||||||||||
| OGP | Q15365. | ||||||||||||||||||
| REPRODUCTION-2DPAGE | IPI00016610. | ||||||||||||||||||
| UCD-2DPAGE | Q15365. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PeptideAtlas | Q15365. | ||||||||||||||||||
| PRIDE | Q15365. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000303577; ENSP00000305556; ENSG00000169564. | ||||||||||||||||||
| GeneID | 5093. | ||||||||||||||||||
| KEGG | hsa:5093. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 5093. | ||||||||||||||||||
| GeneCards | GC02P070314. | ||||||||||||||||||
| H-InvDB | HIX0023976. | ||||||||||||||||||
| HGNC | HGNC:8647. PCBP1. | ||||||||||||||||||
| HPA | CAB037113. | ||||||||||||||||||
| MIM | 601209. gene. | ||||||||||||||||||
| neXtProt | NX_Q15365. | ||||||||||||||||||
| PharmGKB | PA32986. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | prNOG13022. | ||||||||||||||||||
| HOGENOM | HBG445439. | ||||||||||||||||||
| HOVERGEN | HBG053520. | ||||||||||||||||||
| InParanoid | Q15365. | ||||||||||||||||||
| OMA | NISERNC. | ||||||||||||||||||
| OrthoDB | EOG46WZ8K. | ||||||||||||||||||
| PhylomeDB | Q15365. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Reactome | REACT_1675. mRNA Processing. REACT_71. Gene Expression. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q15365. | ||||||||||||||||||
| Bgee | Q15365. | ||||||||||||||||||
| CleanEx | HS_PCBP1. | ||||||||||||||||||
| Genevestigator | Q15365. | ||||||||||||||||||
| GermOnline | ENSG00000169564. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR004087. KH. IPR004088. KH_type_1. IPR018111. KH_type_1_subgr. [Graphical view] | ||||||||||||||||||
| KO | K12889. | ||||||||||||||||||
| Pfam | PF00013. KH_1. 3 hits. [Graphical view] | ||||||||||||||||||
| SMART | SM00322. KH. 3 hits. [Graphical view] | ||||||||||||||||||
| PROSITE | PS50084. KH_TYPE_1. 3 hits. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| NextBio | 19644. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | PCBP1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q15365 Secondary accession number(s): Q13157, Q14975 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 2 Human chromosome 2: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with